Update (1000ET): Nobody was more relieved to see the Biden-Harris ticket prevail last week than Dr. Anthony Fauci (arguably, the first job that Biden saved was Fauci’s). Now the good doctor is joining the vaccine market pump-fest, by telling reporters that his favorite biotech company, Moderna (which he has been pumping virtually since its first vaccine-related press release) might exhibit similarly effective results to Pfizer’s vaccine.
- TOP NIH OFFICIAL DR. FAUCI: MODERNA MAY SIMILAR RESULTS AS THE PFIZER VACCINE.
This, despite recently released data calling the vaccine’s effectiveness into question.
* * *
Update (0910ET): Pfizer shares are now up 16% with less than a half hour to go before the open.
Meanwhile, for traders still turning over that “90% efficacy” figure (the fact that so many infections were in the placebo group is surely a good sign, the scientists said) in their heads, CNBC has offered some helpful points of comparison.https://platform.twitter.com/embed/index.html?dnt=false&embedId=twitter-widget-0&frame=false&hideCard=false&hideThread=false&id=1325802606267133953&lang=en&origin=https%3A%2F%2Fwww.zerohedge.com%2Fmarkets%2Fpfizer-biontech-trials-show-covid-19-vaccine-more-90-effective&siteScreenName=zerohedge&theme=light&widgetsVersion=ed20a2b%3A1601588405575&width=550px
Some good info on CNBC showing how great 90% effectiveness is for a vaccine. How effective current vaccines are:
Measles: 97%
Smallpox: 95%
Chicken pox: 92%
Seasonal flu: 40-60%— ForexLive (@ForexLive) November 9, 2020
Who else is ready for the ‘roaring twenties’ pt II?https://platform.twitter.com/embed/index.html?dnt=false&embedId=twitter-widget-1&frame=false&hideCard=false&hideThread=false&id=1325803021524197378&lang=en&origin=https%3A%2F%2Fwww.zerohedge.com%2Fmarkets%2Fpfizer-biontech-trials-show-covid-19-vaccine-more-90-effective&siteScreenName=zerohedge&theme=light&widgetsVersion=ed20a2b%3A1601588405575&width=550px
I wrote this yesterday
IF this vaccine works and IF we get another spending package to bridge the gap between now and ppl getting it I think 2021-2022 could see a massive boom in the economy and markets
Roaring 20s are on the tablehttps://t.co/1nLMwHLQjS pic.twitter.com/ciGMdM7xed— Ben Carlson (@awealthofcs) November 9, 2020
* * *
Update (0820ET): Adding to the positive COVID-19 vaccine news that has goosed stocks Monday morning, the FDA has officially awarded Novovax, considered a second-tier COVID-19 vaccine competitor, a “fast track” designation, while WSJ and other media are reporting that Pfizer’s vaccine could get emergency approval and head into distribution by the end of the month.
READ MORE: